Published in Eur J Immunol on May 01, 1997
Human natural killer cells. Blood (2008) 7.37
Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 4.33
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med (1998) 3.09
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 3.08
Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med (1998) 2.87
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57
A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med (1999) 2.36
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med (1999) 1.77
A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med (2002) 1.67
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood (2009) 1.62
Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci (2012) 1.55
Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med (1999) 1.45
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med (1998) 1.43
UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci U S A (2002) 1.36
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med (1999) 1.29
Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis. Infect Immun (1998) 1.28
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A (2003) 1.27
IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest (2002) 1.24
Analysis of HLA-E expression in human tumors. Immunogenetics (2003) 1.23
Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23
The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides. J Exp Med (1999) 1.22
Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog (2014) 1.20
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes. Proc Natl Acad Sci U S A (2011) 1.17
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J Clin Invest (2002) 1.14
Qa-1b binds conserved class I leader peptides derived from several mammalian species. J Exp Med (1998) 1.12
HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology (2000) 1.07
Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (2014) 1.07
A novel system of polymorphic and diverse NK cell receptors in primates. PLoS Genet (2009) 1.06
Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med (2001) 1.05
Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells. Semin Immunol (2011) 1.05
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. J Biomed Biotechnol (2010) 1.05
High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med (2011) 1.04
Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. J Immunol (2012) 1.04
Effects of Peptide on NK cell-mediated MHC I recognition. Front Immunol (2014) 1.04
The selection of M3-restricted T cells is dependent on M3 expression and presentation of N-formylated peptides in the thymus. J Exp Med (1999) 1.00
Production, crystallization, and preliminary X-ray analysis of the human MHC class Ib molecule HLA-E. Protein Sci (1998) 0.98
The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors. Viruses (2009) 0.97
Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach. BMC Immunol (2001) 0.96
Genes encoding putative natural killer cell C-type lectin receptors in teleostean fishes. Proc Natl Acad Sci U S A (2003) 0.94
A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells. PLoS Pathog (2016) 0.93
Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. PLoS Pathog (2012) 0.93
Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology (2013) 0.92
The immunogenetics of Behçet's disease: A comprehensive review. J Autoimmun (2015) 0.91
A GATA factor mediates cell type-restricted induction of HLA-E gene transcription by gamma interferon. Mol Cell Biol (2004) 0.90
Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell Mol Immunol (2014) 0.90
Natural killer cells fertile with receptors for HLA-G? Proc Natl Acad Sci U S A (1999) 0.90
Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants. Immunogenetics (2004) 0.89
Natural killer cell receptors and their ligands in liver diseases. Med Mol Morphol (2009) 0.88
Human herpesvirus 7 u21 downregulates classical and nonclassical class I major histocompatibility complex molecules from the cell surface. J Virol (2010) 0.85
Co-evolution of MHC class I and variable NK cell receptors in placental mammals. Immunol Rev (2015) 0.85
HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load. J Infect Dis (2012) 0.83
Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clin Exp Immunol (2013) 0.83
The DY genes of the cattle MHC: expression and comparative analysis of an unusual class II MHC gene pair. Immunogenetics (2004) 0.82
A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1. J Virol (2015) 0.82
Genetic and proteomic analysis of the MHC class I repertoire from four ovine haplotypes. Immunogenetics (2008) 0.81
AIDS in chimpanzees: the role of MHC genes. Immunogenetics (2017) 0.80
Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome. Front Immunol (2015) 0.80
HLA-E: a novel player for histocompatibility. J Immunol Res (2014) 0.80
Polymorphism and conservation of the genes encoding Qa1 molecules. Immunogenetics (2004) 0.80
The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch. Immunogenetics (2015) 0.80
Irradiation-induced up-regulation of HLA-E on macrovascular endothelial cells confers protection against killing by activated natural killer cells. PLoS One (2010) 0.78
Mammalian non-classical major histocompatibility complex I and its receptors: Important contexts of gene, evolution, and immunity. Indian J Hum Genet (2014) 0.78
Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases. J Immunol Res (2016) 0.77
Increased HLA-E expression in white matter lesions in multiple sclerosis. Immunology (2012) 0.77
HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome. Stem Cells Int (2015) 0.77
Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey. Immunogenetics (2007) 0.76
Extended sequence of the turkey MHC B-locus and sequence variation in the highly polymorphic B-G loci. Immunogenetics (2011) 0.76
The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection. Clin Exp Immunol (2016) 0.76
The role of MHC class Ib-restricted T cells during infection. Immunogenetics (2016) 0.75
A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule. J Biol Chem (2012) 0.75
NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts. PLoS One (2016) 0.75
The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease. Int J Mol Sci (2016) 0.75
Pas de deux: natural killer receptors and MHC class I ligands in primates. Curr Genomics (2007) 0.75
Expression and alternative splicing of classical and nonclassical MHCI genes in the hippocampus and neuromuscular junction. Mol Cell Neurosci (2016) 0.75
Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity (2017) 0.75
Transmembrane Helices Are an Overlooked Source of Major Histocompatibility Complex Class I Epitopes. Front Immunol (2017) 0.75
CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination. Curr Opin Immunol (2017) 0.75
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature (1987) 4.66
A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (1994) 3.05
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet (1993) 2.71
Lifetime exposure to environmental lead and children's intelligence at 11-13 years: the Port Pirie cohort study. BMJ (1996) 2.67
The association between the HLA system and disease. Prog Med Genet (1977) 2.67
Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65
Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol (1979) 2.53
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature (1997) 2.41
Structure and dimerization of a soluble form of B7-1. Immunity (2000) 2.33
Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol (1982) 2.30
Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity (2001) 2.30
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. J Med Chem (1996) 2.29
The molecular structure of cell adhesion molecules. Annu Rev Biochem (1997) 2.18
CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest (2001) 2.15
The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell (1997) 2.10
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J Exp Med (1988) 1.97
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat Struct Biol (1999) 1.88
Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol (1981) 1.87
Crystal structure of the N-terminal domain of sialoadhesin in complex with 3' sialyllactose at 1.85 A resolution. Mol Cell (1998) 1.86
Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J (1999) 1.84
Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment. Nat Immunol (2001) 1.74
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol (1995) 1.73
Functions of fibroblast growth factors and their receptors. Curr Biol (1995) 1.70
Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature (1994) 1.67
Gene polymorphism in Netherton and common atopic disease. Nat Genet (2001) 1.66
A human X-linked antigen defined by a monoclonal antibody. Somatic Cell Genet (1980) 1.64
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest (1976) 1.59
HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2. J Exp Med (1978) 1.56
Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor. Proc Natl Acad Sci U S A (1997) 1.55
Role of cellular immunity in protection against HIV infection. Adv Immunol (1997) 1.51
Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem (1999) 1.50
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50
Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev (1997) 1.49
Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science (1995) 1.48
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J (2004) 1.46
Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. Structure (1994) 1.44
Crystal structure of the extracellular region of human tissue factor. Nature (1994) 1.43
Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol (2003) 1.42
Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem (1997) 1.41
DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine (1998) 1.40
First steps towards effective methods in exploiting high-throughput technologies for the determination of human protein structures of high biomedical value. Acta Crystallogr D Biol Crystallogr (2006) 1.40
Reduced allorecognition of adenovirus-2 infected cells. J Immunol (1987) 1.38
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity (1996) 1.38
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med (1996) 1.36
Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS (1998) 1.35
Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J Biol Chem (1996) 1.32
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol (1998) 1.32
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell (1994) 1.29
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol (1992) 1.29
The human low affinity Fcgamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J Biol Chem (2001) 1.28
Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity (1996) 1.27
Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell (1998) 1.25
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? Immunol Lett (2001) 1.24
Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. Gut (1981) 1.23
Crystal structure of a cytokine-binding region of gp130. EMBO J (1998) 1.23
Continuous and discontinuous changes in the unit cell of HIV-1 reverse transcriptase crystals on dehydration. Acta Crystallogr D Biol Crystallogr (1998) 1.22
Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. Protein Eng (1993) 1.21
Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J Biol Chem (2000) 1.21
Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. Biochemistry (1995) 1.20
Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Structure (1999) 1.17
Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent. J Biol Chem (1995) 1.16
Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: application to glycoprotein crystallization. Protein Sci (1999) 1.15
3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes. Proc Natl Acad Sci U S A (1998) 1.14
Peptide selection by class I molecules of the major histocompatibility complex. Curr Biol (1993) 1.14
HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med (1995) 1.14
Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding. Protein Sci (1999) 1.14
Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity (1999) 1.12
Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime. Vaccine (1999) 1.11
Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer. Int J Cancer (1992) 1.11
Alpha4 integrin binding interfaces on VCAM-1 and MAdCAM-1. Integrin binding footprints identify accessory binding sites that play a role in integrin specificity. J Biol Chem (1997) 1.11
Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7. Eur J Immunol (1995) 1.10
Assembly and crystallization of the complex between the human T cell coreceptor CD8alpha homodimer and HLA-A2. Protein Sci (1998) 1.10
Genetic modulation of antigen presentation by HLA-B27 molecules. J Exp Med (1992) 1.09
The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2. Proc Natl Acad Sci U S A (1998) 1.08
An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur J Immunol (1996) 1.07
Production and crystallization of MHC class I B allele single peptide complexes. FEBS Lett (1996) 1.07
Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J Immunol (2000) 1.04
RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. Int Immunol (2000) 1.03
The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site. Protein Sci (1999) 1.03
Structural basis of cell-cell adhesion by NCAM. Nat Struct Biol (2000) 1.03
A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. Science (1992) 1.02
Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80). AIDS (1996) 1.01
MHC superfamily structure and the immune system. Curr Opin Struct Biol (1999) 1.00
Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. J Med Chem (1996) 0.99
Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain. Immunogenetics (1993) 0.98
Production, crystallization, and preliminary X-ray analysis of the human MHC class Ib molecule HLA-E. Protein Sci (1998) 0.98
Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1. Acta Crystallogr D Biol Crystallogr (2001) 0.97
Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV. J Med Primatol (1993) 0.97
Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes. Eur J Immunol (1997) 0.97
Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition. J Immunol (1994) 0.96
Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53. Eur J Immunol (2001) 0.95
The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure (1995) 0.94
An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Mol Med (2000) 0.94